Rankings
▼
Calendar
IONS Q1 2018 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$12B
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$144M
+24.7% YoY
Gross Profit
$144M
100.0% margin
Operating Income
-$3M
-2.3% margin
Net Income
-$1M
-1.0% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
-16.2%
Cash Flow
Operating Cash Flow
$13M
Free Cash Flow
$10M
Stock-Based Comp.
$28M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$912M
Stockholders' Equity
$301M
Cash & Equivalents
$228M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$144M
$116M
+24.7%
Gross Profit
$144M
$33M
+335.5%
Operating Income
-$3M
$19M
-116.9%
Net Income
-$1M
$9M
-115.8%
Revenue Segments
Commercial
$42M
50%
SPINRAZA Royalties
$41M
49%
Licensing and Other Royalties
$942,000
1%
← FY 2018
All Quarters
Q2 2018 →